Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Scalp cooling effectively reduces hair loss from chemotherapy.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

No treatment fully prevents hair loss from chemotherapy yet.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.